ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Taxation/Internal Revenue Code TAX

Issues related to reform of tax code and possible timing of any such reform (no bill number yet)

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Commerce, Dept of (DOC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE

Consumer Issues/Safety/Products CSP

S. 525 and related legislative proposals regarding prescription drug importation and safety issues

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Commerce, Dept of (DOC); State, Dept of (DOS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS)

Bills named: S. 525 (112th)

Pharmacy PHA

FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) V (no bill number yet)

Contacted: SENATE; State, Dept of (DOS); Health Resources & Services Administration (HRSA); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

HR 6331 - patent issues associated with anti-biotics S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 4899 (112th), S. 3677 (112th), H.R. 6331 (112th)

Health Issues HCR

HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to health care reform legislation and implementation, including the newly-created Independent Payment Advisory Board Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) HR 6331 - issues related to legislation regarding development of antibiotics HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to health care reform legislation and implementation, including transparency ("Sunshine") reporting requirements 340B Drug Pricing program issues, including expansion of eligible entities and impacts of health care reform changes

Contacted: Commerce, Dept of (DOC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1790 (112th), H.R. 3590 (112th), H.R. 4872 (112th), H.R. 6331 (112th)

Medicare/Medicaid MMM

HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program HR 3590, S. 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicaid price reporting, rebate calculation, and expansion of eligible utilization Issues related to identification and correction of medical edit codes

Contacted: Health & Human Services, Dept of (HHS); State, Dept of (DOS); Health Resources & Services Administration (HRSA); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1790 (112th), H.R. 3590 (112th), H.R. 4872 (112th)